Tests in

p16 (9p) FISH

  • Test Code:
    8615
  • Department:
    Cancer FISH
  • Test Synonyms:
View Test

Pantothenate Kinase-Associated Neurodegeneration (PKAN), PANK2, Sequencing

  • Test Code:
    2231
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Hallervorden-Spatz Syndrome • PANK2 • NBIA
View Test

Parkinson’s Disease Panel

  • Test Code:
    2240
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Parkinsons • ATP13A2 • ATP1A3 • CSF1R • DCTN1 • FBXO7 • GBA • GCH1 • LRRK2 • MAPT • PARK2 • PARK7 • PINK1 • PLA2G6 • POLG • SLC6A3 • SNCA • TAF1 • TH • VPS35
View Test

PDGFRA - GIST

  • Test Code:
    5250
  • Department:
    Solid Tumors
  • Test Synonyms:
    PDGFRA mutation screening for gastrointestinal stromal tumor (GIST) (exons 12, 14, 18)
View Test

PIK3CA Mutation Analysis

  • Test Code:
    5270
  • Department:
    Solid Tumors
  • Test Synonyms:
    PIK3CA • PI3 Kinase
View Test

Platelet Disorders Panel

  • Test Code:
    2250
  • Department:
    Molecular Genetics
  • Test Synonyms:
    A2M • ABCA1 • ANKRD26 • ANO6 • AP3B1 • Bernard-Soulier • BLOC1S6 • CD36 • Coagulation disorders • Comprehensive Bleeding Disorder Panel • DHCR24 • DPAGT1 • DTNBP1 • F2 • F5 • F7 • F8 • F9 • F10 • F11 • F13A1 • F13B • FERMT3 • FGA • FGB • FGG • FLNA • GATA1 • GFI1B • GGCX; • Glanzmann thromlasthenia • GNAQ • GNAS • GP1BA • GP6 • GP9 • Hermansky-Pudlak • HOXA11 • HPS1 • HPS3 • HPS4 • HPS5 • HPS6 • ITGA2 • ITGA2B • ITGB3 • KLKB1 • LMAN1 • LYST • MCFD2 • MASTL • MLPH • MPL • MYH9 • MYO5A • NBEAL2 • P2RX1 • P2RY12 • PLA2G4A • PLA2G7 • Platelet dysfunctions • PLAU • RAB27A • RASGRP2 • RUNX1 • SERPINA1 • SERPINE1 • SERPINF2 • STIM1 • TBXA2R • TBXAS1 • Thrombocytopenia • USF1 • VIPAS39 • VKORC1 • Von Willebrand Disease • VPS33B • VWF • WAS • Wiskott-Aldrich
View Test

PLCG2 Mutation Testing

View Test

PML/RARA t(15;17) FISH

  • Test Code:
    8636 • 8637 FFPE
  • Department:
    Cancer FISH
  • Test Synonyms:
    APL
View Test

PML-RARA Quantitative RT-PCR (Acute Promyelocytic Leukemia)

  • Test Code:
    5300
  • Department:
    Hematological Malignancies
  • Test Synonyms:
    15;17 translocation PCR • Acute Promyelocytic Leukemia (APL) PCR • M3 leukemia diagnosis and monitoring
View Test

Prader-Willi / Angelman Syndrome Methylation and Deletion/Duplication

View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More